Processing Your Payment

Please do not leave this page until complete. This can take a few moments.

August 4, 2015

Oxford Immunotec revenue up, reports 2Q loss

Oxford Immunotec, a diagnostics company with U.S. headquarters in Marlborough, announced revenue growth in the second quarter of 2015 alongside continued overall losses.

The biotech company took in revenue of $14.3 million, up 21 percent and led by sales in the U.S. and Asia. U.S. revenue was $7.3 million in the second quarter of 2015 representing 33 percent growth over $5.5 million in the same period in 2014. Meanwhile, revenue from was $5.1 million, representing 6 percent growth over $4.5 million in the second quarter of 2014.

"Our sales performance came in above our expectations … and we are pleased with the regulatory and clinical progress we are making on our T-SPOT.CMV test,” said Dr. Peter Wrighton-Smith, CEO.

The company recently developed a laboratory test that measures a patient's immunity to cytomegalovirus (CMV), a herpes virus. The company does not yet have a product that has secured all regulatory approvals to be put into the market.

Oxford said it expects revenue for the year of between $61 and $64 million, representing 23 to 29 percent year-over-year growth.

Sign up for Enews

WBJ Web Partners

0 Comments

No More articles left

To read more, please
Login or Register (free)

 

To ensure the best experience on our website, articles cannot be read without allowing cookies. Please allow cookies to continue reading. Our privacy policy

Allow Cookies